Two-Tier Specialty Drug Policy: Part D Plans Gain Formulary Flexibility But Impact May Be Limited

 
• By Cathy Kelly
Two Tiers May Sweeten Price Negotiations For Medicare Part D Plans

More from Pricing Debate

More from Market Access